Onabotulinumtoxina Intradetrusorial Injections and NGF Expression (Onab/A-NGF)

This study has been completed.
Sponsor:
Collaborator:
Allergan
Information provided by (Responsible Party):
Antonella Giannantoni, University Of Perugia
ClinicalTrials.gov Identifier:
NCT01629433
First received: June 20, 2012
Last updated: June 25, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)